Target intelligence / Profile preview

p53-Independent Apoptosis Pathway

Molecular classification
Signaling pathway, Apoptotic pathway
01

Overview

The p53-independent apoptosis pathway refers to mechanisms of programmed cell death that occur without the involvement of the tumor suppressor protein p53. Triggering events include DNA damage, ribosomal stress, telomere dysfunction, and cytokine signaling (e.g., TNF-α). Key molecular mediators include SLFN11, GCN2 kinase, ZAKα, and the JNK pathway. This pathway serves as a backup mechanism for eliminating damaged or abnormal cells, especially in cancers with TP53 mutations. Disruption of this pathway, such as through loss of SLFN11, can lead to chemoresistance. Targeting this pathway offers potential therapeutic strategies for TP53-mutant tumors.

Other names
p53-independent cell deathAlternative apoptosis pathwayNon-p53 mediated apoptosis
02

Mechanism of action

Various, depending on the specific pathway. Examples include: Activation of JNK pathway, Activation of death receptors (e.g. TNF-alpha receptor), Ribosome stalling and ZAKα-mediated activation of apoptosis

03

Biological functions

ApoptosisCell deathDNA damage responseRibotoxic stress responseSignal transduction
04

Disease associations

CancerChemoresistance
05

Safety considerations

Off-target effects of JNK inhibitorsPotential for promoting tumor survival if apoptosis is incompletely blocked
06

Interacting drugs

Chemotherapeutic agents (e.g., Paclitaxel)
07

Biomarkers

SLFN11 expression (predictive of sensitivity)p53 statusJNK activation

Beyond the preview

Go deeper on p53-Independent Apoptosis Pathway.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on p53-Independent Apoptosis Pathway.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call